CH619704A5 - Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof - Google Patents
Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof Download PDFInfo
- Publication number
- CH619704A5 CH619704A5 CH1016678A CH1016678A CH619704A5 CH 619704 A5 CH619704 A5 CH 619704A5 CH 1016678 A CH1016678 A CH 1016678A CH 1016678 A CH1016678 A CH 1016678A CH 619704 A5 CH619704 A5 CH 619704A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- hydrogen
- alkyl
- compound
- feed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Die Erfindung wird anhand der folgenden Beispiele weiter erläutert. The invention is further illustrated by the following examples.
619704 619704
8 8th
Beispiel 1 example 1
Herstellung von l-Methoxy-3-(4,5,6,7-tetrahydrobenzo-[b]--thien-4-yl)-harnstoff Preparation of l-methoxy-3- (4,5,6,7-tetrahydrobenzo- [b] - thien-4-yl) urea
Man kühlt eine Mischung aus 5 g Methoxyamin-hydro-chlorid und 60 ml Methylenchlorid auf etwa 15°C ab und setzt 6 g Triäthylamin in 15 ml Methylenchlorid zu. Nach 20 Minuten gibt man im Verlaufe von 20 Minuten bei 15 bis 20°C 5,38 g 4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl-isocyanat in 20 ml Methylenchlorid zu. Nach dem Rühren während einer Stunde filtriert man die Mischung und wäscht das Filtrat mit Wasser und schliesslich mit einer wässrigen Natrium-bicarbonatlösung. Die Lösung wird dann getrocknet und eingedampft, wobei ein weisser Feststoff anfällt, der aus einer Aceton/Hexan-Mischung umkristallisiert wird und 5,1 g l-Methoxy-3-(4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl)-harn-stoff mit einem Schmelzpunkt von 138,5 bis 141°C ergibt. A mixture of 5 g of methoxyamine hydrochloride and 60 ml of methylene chloride is cooled to about 15 ° C. and 6 g of triethylamine in 15 ml of methylene chloride are added. After 20 minutes, 5.38 g of 4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl isocyanate in 20 ml of methylene chloride are added in the course of 20 minutes at 15 to 20 ° C. After stirring for one hour, the mixture is filtered and the filtrate is washed with water and finally with an aqueous sodium bicarbonate solution. The solution is then dried and evaporated to give a white solid, which is recrystallized from an acetone / hexane mixture and 5.1 g of l-methoxy-3- (4,5,6,7-tetrahydrobenzo- [b] - thien-4-yl) urea with a melting point of 138.5 to 141 ° C.
In ähnlicher Weise erhält man, wenn man anstelle von Methoxyamin-hydrochlorid Äthoxyamin-hydrochlorid bzw. n-Butoxyamin-hydrochlorid einsetzt, l-Äthoxy-3-(4,5,6,7--tetrahydrobenzo-[b]-thien-4-yl)-harnstoff bzw. l-Butoxy-3--(4,5,6,7-tetrahydrobenzo-[b]-thien-4-yl)-harnstoff. Similarly, if instead of methoxyamine hydrochloride ethoxyamine hydrochloride or n-butoxyamine hydrochloride is used, l-ethoxy-3- (4,5,6,7 - tetrahydrobenzo- [b] -thien-4 -yl) urea or l-butoxy-3 - (4,5,6,7-tetrahydrobenzo- [b] thien-4-yl) urea.
Beispiel 2 Example 2
Herstellung von I-(Benzyloxy)-3-(4,5,6,7-tetrahydrobenzo--[ b ]-thien-4-yl)-harnstoff Preparation of I- (benzyloxy) -3- (4,5,6,7-tetrahydrobenzo - [b] thien-4-yl) urea
In der in Beispiel 1 beschriebenen Weise setzt man O-Ben-zyl-hydroxylamin-hydrochlorid mit 4,5,6,7-Tetrahydrobenz--[ b 1 -thien-4-yi-isocyanat um, wobei man l-(Benzyloxy)-3--(4,5,6,7-tetrahydrobenzo-[b]-thien-4-yl)-harnstoff erhält, den man aus einer Mischung von 95%igem Äthylalkohol und Methylisobutylketon umkristallisiert. Das Produkt schmilzt bei 96,5 bis 99°C. In the manner described in Example 1, O-benzyl hydroxylamine hydrochloride is reacted with 4,5,6,7-tetrahydrobenz - [b 1 -thien-4-yi-isocyanate, l - (benzyloxy) -3 - (4,5,6,7-tetrahydrobenzo- [b] thien-4-yl) urea is obtained, which is recrystallized from a mixture of 95% ethyl alcohol and methyl isobutyl ketone. The product melts at 96.5 to 99 ° C.
Beispiel 3 Example 3
Herstellung von l-Hydroxy-l-methyl-3-(4,5,6,7-tetrah.yd.ro-benzo-[b]-thien-4-yl)-harnstoff Preparation of l-hydroxy-l-methyl-3- (4,5,6,7-tetrah.yd.ro-benzo [b] thien-4-yl) urea
In der in Beispiel 1 beschriebenen Weise setzt man N-Me-thyl-hydroxylamin-hydrochlorid mit 4,5,6,7-Tetrahydro-benzo-[b]-thien-4-yl-isocyanat um, wobei man 1-Hydroxy-l--methyl-3-(4,5,6,7-tetrahydrobenzo-[b]-thien-4-yl)-harnstoff erhält, den man aus einer Aceton/Hexan/Äther-Mischung umkristallisiert, wobei man Kristalle mit einem Schmelzpunkt von 98 bis 102°C erhält. In the manner described in Example 1, N-methyl-hydroxylamine hydrochloride is reacted with 4,5,6,7-tetrahydro-benzo [b] thien-4-yl isocyanate, 1-hydroxy- l - methyl-3- (4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl) urea is obtained, which is recrystallized from an acetone / hexane / ether mixture, with crystals having a Receives melting point of 98 to 102 ° C.
Beispiel 4 Example 4
Herstellung von l-Methoxy-l-methyl-3-(4,5,6,7-tetrahydro-benzo-[ b ]-thien-4-yl)-harnstoff Preparation of l-methoxy-l-methyl-3- (4,5,6,7-tetrahydro-benzo [b] thien-4-yl) urea
In der in Beispiel 1 beschriebenen Weise setzt man N,0--Dimethyl-hydroxylamin-hydrochlorid mit 4,5,6,7-Tetrahy-drobenzo-[b]-thien-4-yl-isocyanat um, wobei man 1-Methoxy--1 -methy l-3-(4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl)-harnstoff erhält, der aus einer Aceton/Hexan/Äther-Mischung umkristallisiert wird und ein Produkt mit einem Schmelzpunkt von 60 bis 62,5°C ergibt. In the manner described in Example 1, N, 0-dimethyl-hydroxylamine hydrochloride is reacted with 4,5,6,7-tetrahy-drobenzo- [b] -thien-4-yl isocyanate, with 1-methoxy - 1-Methyl l-3- (4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl) urea, which is recrystallized from an acetone / hexane / ether mixture and a product with gives a melting point of 60 to 62.5 ° C.
Beispiel 5 Example 5
Herstellung von l-Phenäthyl-3-(4,5,6,7-tetrahydrobenzo-[b]--thien-4-yl)-harnstoff Preparation of l-phenethyl-3- (4,5,6,7-tetrahydrobenzo- [b] - thien-4-yl) urea
Unter einer Stickstoffatmosphäre setzt man eine Mischung aus 3,82 g Phenäthylamin und 100 ml Diäthyläther mit 5,38 g 4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl-isocyanat in 25 ml Diäthyläther um, wobei man das Isocyanat in dem Äthyläther tropfenweise zusetzt. Nach dem einstündigen Verrühren bei Raumtemperatur filtriert man die Mischung und wäscht sie mit Äther, wobei man 7,9 g l-Phenäthyl-3-(4,5,6,7--tetrahydrobenzo-[b]-thien-4-yl)-harnstoff mit einem Schmelzpunkt von 163 bis 166°C erhält. Under a nitrogen atmosphere, a mixture of 3.82 g of phenethylamine and 100 ml of diethyl ether is reacted with 5.38 g of 4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl isocyanate in 25 ml of diethyl ether, where the isocyanate is added dropwise in the ethyl ether. After stirring for one hour at room temperature, the mixture is filtered and washed with ether, 7.9 g of l-phenethyl-3- (4,5,6,7-tetrahydrobenzo- [b] thien-4-yl) -Urea with a melting point of 163 to 166 ° C.
In ähnlicher Weise erhält man, wenn man Methylamin, Äthylamin, Isopropylamin, n-Hexylamin bzw. Cyclohexyl-amin mit dem oben erwähnten Isocyanat umsetzt, 1-Methyl-, 1-ÄthyI-, 1-Isopropyl-, 1-Hexyl- bzw. l-Cyclohexyl-3-(4,5,6,7--tetrahydrobenzo-[b]-thien-4-yl)-hamstoff. Similarly, if methylamine, ethylamine, isopropylamine, n-hexylamine or cyclohexylamine are reacted with the isocyanate mentioned above, 1-methyl-, 1-ethylI, 1-isopropyl-, 1-hexyl- or 1-hexyl- or l-Cyclohexyl-3- (4,5,6,7 - tetrahydrobenzo- [b] thien-4-yl) urea.
Beispiel 6 Example 6
Herstellung von 1 ,l-Dimethyl-3-(4,.5,6,7-tetrahydrobenzo-[bJ--thien-4-yl)-harnstoff Preparation of 1, l-dimethyl-3- (4, .5,6,7-tetrahydrobenzo- [bJ - thien-4-yl) urea
Man beschickt eine Lösung von 6,27 g 4,5,6,7-Tetra-hydrobenzo-[b]-thien-4-yl-isocyanat in 200 ml Diäthyläther unter Rühren mit gasförmigem Dimethylamin, das man über ein Kapillarrohr zuführt. Nach einer Gaseinleitungszeit von 0,5 Stunden unterbricht man die Gaszufuhr und dampft die Mischung zur Trockne ein, wobei ein fester Rückstand anfällt. Dieser Rückstand wird aus einer Aceton/Hexan/Äther-Mischung umkristallisiert und ergibt l,l-Dimethyl-3-(4,5,6,7--tetrahydrobenzo-[b]-thien-4-yl)-harnstoff, der bei 117 bis 120°C schmilzt. A solution of 6.27 g of 4,5,6,7-tetra-hydrobenzo [b] thien-4-yl isocyanate in 200 ml of diethyl ether is charged with gaseous dimethylamine, which is fed in through a capillary tube. After a gas introduction time of 0.5 hours, the gas supply is interrupted and the mixture is evaporated to dryness, a solid residue being obtained. This residue is recrystallized from an acetone / hexane / ether mixture and gives l, l-dimethyl-3- (4,5,6,7 - tetrahydrobenzo- [b] -thien-4-yl) urea, which at 117 to 120 ° C melts.
Beispiel 7 Example 7
Herstellung von I-Benzyl-3-(4,5,6,7-tetrahydrobenzo-[b]--thien-4-yl)-harnstoff Preparation of I-benzyl-3- (4,5,6,7-tetrahydrobenzo- [b] - thien-4-yl) urea
In der in Beispiel 1 beschriebenen Weise, jedoch mit dem Unterschied, dass man anstelle von Methylenchlorid Diäthyläther verwendet, erhält man durch Umsetzen von Benzyl-amin mit 4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl-isocyanat l-Benzyl-3-(4,5,6,7-tetrahydrobenzo-[b]-thien-4-yl)-harnstoff. Das Produkt schmilzt bei 211 bis 214°C. In the manner described in Example 1, but with the difference that diethyl ether is used instead of methylene chloride, reaction of benzylamine with 4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl- isocyanate l-benzyl-3- (4,5,6,7-tetrahydrobenzo- [b] thien-4-yl) urea. The product melts at 211 to 214 ° C.
Beispiel 8 Example 8
Herstellung von l-Hydroxy-3-(4,5,6,7-tetrahydrobenzo-[b]--thien-4-yl)-harnstoff Preparation of l-hydroxy-3- (4,5,6,7-tetrahydrobenzo- [b] thien-4-yl) urea
Man bereitet die obige Verbindung in der in Beispiel 1 angegebenen Weise durch Umsetzen von 4,5,6,7-Tetrahydro-benzo-[b]-thien-4-y!-isocyanat mit Hydroxylamin-hydrochlo-rid in Gegenwart von Triäthylamin. Das Produkt schmilzt bei 158,5 bis 160,5°C. The above compound is prepared in the manner given in Example 1 by reacting 4,5,6,7-tetrahydrobenzo [b] thien-4-y! Isocyanate with hydroxylamine hydrochloride in the presence of triethylamine. The product melts at 158.5 to 160.5 ° C.
Beispiel 9 Example 9
Herstellung von N-(4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl)--4-morpholincarboxamid Preparation of N- (4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl) -4-morpholine carboxamide
Wenn man in der in Beispiel 1 angegebenen Weise vorgeht, jedoch anstelle von Methylenchlorid Diäthyläther einsetzt und 4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yI-isocyanat mit Morpholin umsetzt, so erhält man N-(4,5,6,7-Tetrahydro-benzo-[b]-thien-4-yl)-4-morpholincarboxamid, das bei 152 bis 154°C schmilzt. If one proceeds in the manner given in Example 1, but uses diethyl ether instead of methylene chloride and 4,5,6,7-tetrahydrobenzo- [b] -thien-4-yI-isocyanate is reacted with morpholine, N- (4 , 5,6,7-tetrahydro-benzo- [b] -thien-4-yl) -4-morpholine carboxamide, which melts at 152 to 154 ° C.
Herstellung von 4,5,6,7-Tetrahydrobenzo-[b]-thien--4-yl-isocyanat Preparation of 4,5,6,7-tetrahydrobenzo [b] thien-4-yl isocyanate
Man rührt 47,6 g 4,5,6,7-Tetrahydrobenzo-[b]-thiophen--4-amin-hydrochlorid in 150 ml Wasser und setzt 350 ml einer 10%igen Natriumhydroxidlösung zu. Man schüttelt die Mischung und extrahiert sie zweimal mit Benzol. Man trocknet den Extrakt und dampft ihn zur Trockne ein, wobei man das Amin erhält, das man unter Stickstoff aufbewahrt. Dann setzt man das Amin tropfenweise unter einer Stickstoffatmosphäre bei 20°C zu 866 ml einer 12,5% igen Lösung von Phosgen in Benzol. Nach dem einstündigen Rühren bei 47.6 g of 4,5,6,7-tetrahydrobenzo- [b] -thiophene-4-amine hydrochloride are stirred in 150 ml of water and 350 ml of a 10% sodium hydroxide solution are added. The mixture is shaken and extracted twice with benzene. The extract is dried and evaporated to dryness to give the amine which is kept under nitrogen. Then the amine is added dropwise under a nitrogen atmosphere at 20 ° C. to 866 ml of a 12.5% solution of phosgene in benzene. After stirring for one hour
5 5
10 10th
15 15
20 20th
25 25th
30 30th
35 35
40 40
45 45
50 50
55 55
60 60
65 65
9 9
619704 619704
Raumtemperatur erhitzt man die Mischung nach und nach auf 60°C und belässt sie während 7 Stunden bei dieser Temperatur. Dann kühlt man die Mischung auf Raumtemperatur ab, dampft sie zur Trockne ein und erhält einen Rückstand, der nach dem Destillieren 22,4 g 4,5,6,7-Tetrahydrobenzo-[b]thien-4-yl-isocyanat mit einem Siedepunkt von 98 bis 101°C/0,6 Torr ergibt. At room temperature, the mixture is gradually heated to 60 ° C. and left at this temperature for 7 hours. The mixture is then cooled to room temperature, evaporated to dryness and a residue is obtained which, after distillation, contains 22.4 g of 4,5,6,7-tetrahydrobenzo- [b] thien-4-yl isocyanate with a boiling point from 98 to 101 ° C / 0.6 Torr.
Herstellung von 4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl--isothiocyanat Preparation of 4,5,6,7-tetrahydrobenzo [b] thien-4-yl isothiocyanate
Man rührt 47,5 g 4,5,6,7-Tetrahydrobenzo-[b]-thiophen--4-aminhydrochlorid in einer Methylchlorid/Wasser-Mischung und setzt nach und nach eine 5% ige Natriumhydroxidlösung zu, bis ein pH-Wert von etwa 10 erreicht ist. Dann trennt man die Methylenchloridschicht ab und extrahiert die wäss-rige Schicht mit Methylenchlorid. Man vereinigt die organischen Schichten, trocknet über Magnesiumsulfat und dampft sie zur Trockne ein, wobei man das ölige Amin erhält. Man rührt das Amin unter einer Stickstoffatmosphäre in 500 ml Äthylacetat und setzt 25,4 g Triäthylamin zu. Nach etwa 15 Minuten gibt man 20,9 g Schwefelkohlenstoff zu, wobei man einen voluminösen Niederschlag erhält. Man setzt weitere 200 ml Äthylacetat zu und pulverisiert den Feststoff mit einem Spatel. Nach lstündigem Rühren gibt man 51,5 g Dicyclohexylcarbodiimid zu und rührt über Nacht. Anschliessend wird die Mischung während 2 Stunden auf etwa 50°C erhitzt und dann abgekühlt. Der Feststoff wird abfiltriert und mit Äthylacetat gewaschen. Das Filtrat wird eingedampft und ergibt eine Mischung aus einem Feststoff und einer überwiegenden Menge Öl. Der Feststoff wird nach der Zugabe von Äther abfiltriert. Das Ätherfiltrat wird zur Trockne eingedampft und ergibt das rohe Isothiocyanat, das auf einer trockenen, mit Siliziumdioxidgel gefüllten Säule chromatographisch gereinigt wird, wozu man eine Petrol- 47.5 g of 4,5,6,7-tetrahydrobenzo- [b] -thiophene-4-amine hydrochloride are stirred in a methyl chloride / water mixture and little by little a 5% sodium hydroxide solution is added until a pH of about 10 is reached. The methylene chloride layer is then separated off and the aqueous layer is extracted with methylene chloride. The organic layers are combined, dried over magnesium sulfate and evaporated to dryness to give the oily amine. The amine is stirred under a nitrogen atmosphere in 500 ml of ethyl acetate and 25.4 g of triethylamine are added. After about 15 minutes, 20.9 g of carbon disulfide are added, giving a voluminous precipitate. A further 200 ml of ethyl acetate are added and the solid is pulverized with a spatula. After stirring for 1 hour, 51.5 g of dicyclohexylcarbodiimide are added and the mixture is stirred overnight. The mixture is then heated to about 50 ° C. for 2 hours and then cooled. The solid is filtered off and washed with ethyl acetate. The filtrate is evaporated to give a mixture of a solid and a predominant amount of oil. The solid is filtered off after the addition of ether. The ether filtrate is evaporated to dryness and gives the crude isothiocyanate, which is purified by chromatography on a dry column filled with silica gel.
äther/Methylenchlorid-Mischung (65/35, Volumen/Volu-' men) verwendet. ether / methylene chloride mixture (65/35, volume / volume) used.
Beispiel 10 Example 10
5 Herstellung von N-(4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl)--4-piperidinthiocarboxamid 5 Preparation of N- (4,5,6,7-tetrahydrobenzo- [b] -thien-4-yl) -4-piperidine thiocarboxamide
Man rührt 50 ml Tetrahydrofuran und 5,85 g 4,5,6,7--Tetrahydrobenzo-[bj-thien-4-yl-isothiocyanat und setzt 2,81 g io Piperidin zu. Man beobachtet eine exotherme Reaktion, wodurch die Temperatur auf etwa 40 bis 50°C steigt. Nach 2% Stunden erhitzt man die Mischung während 3% Stunden zum Sieden am Rückfluss. Nach dem Rühren über Nacht dampft man die Mischung zur Trockne ein und erhält einen klebri-15 gen gelbbraunen Feststoff. Man versetzt dieses Material mit Äther und erhält ein fast weisses, unlösliches Produkt. Das in einer Menge von 5,25 g erhaltene rohe Produkt schmilzt bei 102 bis 104°C. 50 ml of tetrahydrofuran and 5.85 g of 4,5,6,7-tetrahydrobenzo- [bj-thien-4-yl isothiocyanate are stirred in and 2.81 g of io piperidine are added. An exothermic reaction is observed, causing the temperature to rise to about 40 to 50 ° C. After 2% hours, the mixture is refluxed for 3% hours. After stirring overnight, the mixture is evaporated to dryness and a sticky yellow-brown solid is obtained. This material is mixed with ether and an almost white, insoluble product is obtained. The crude product obtained in an amount of 5.25 g melts at 102 to 104 ° C.
20 Beispiel 11 20 Example 11
Die in der folgenden Tabelle I angegebenen Verbindungen erhält man unter Anwendung der in den Beispielen 1 bis 10 angegebenen Verfahrensweisen. The compounds listed in Table I below are obtained using the procedures outlined in Examples 1-10.
25 25th
30 30th
ivj « x ! II - c- ivj «x! II - c-
N N
y y
*2 * 2
*3 * 3
619704 619704
10 10th
tabelle i table i
Ri' Ri '
R, R,
Reaktionslösungsmittel Reaction solvent
Schmelzpunkt °C Melting point ° C
-ch3 -ch3
h h h h
s s
-ch3 -ch3
h h h h
o O
-ch3 -ch3
h h h h
o O
-ch3 -ch3
h h h h
o h o h
-ch3 -ch3
h s h s
h H
-ch3 -ch3
h o h o
h H
-ch3 -ch3
h o h o
h h h h
h o h o
h h h h
h o h o
h h h h
h o h o
h h h h
h o h o
h h h h
h s h s
h h h h
h o h o
h h h h
h o h o
h h h h
h o h o
h h h h
h o h o
h h h h
h s h s
h h h h
h o h o
h h h h
h s h s
h h h h
h s h s
h h h h
h s h s
h h h h
h s h s
h h h h
h s h s
h h h h
h s h s
h h h h
h o h o
h h h h
h H
0 0
h h h h
h H
0 0
h h h h h h h h h h h h h h h h h h h h
h h h h
h h h h
h h h h h h h h h h
h h h h h h
Äthyl ethyl
Äthyl sec-Butyl n-Hexyl Ethyl sec-butyl n-hexyl
Äthyl sec-Butyl n-Hexyl Ethyl sec-butyl n-hexyl
-chj,CH=ch2 -chj, CH = ch2
-ch2co2c2h5 -ch2co2c2h5
-ch -ch
-(ch,),--(ch2)6- - (ch,), - (ch2) 6-
-n-qhç, -n-qhç,
-ch2-ch2-{o) -ch2-ch2- {o)
-ch2ch2-oh -(CH2)b- -ch2ch2-oh - (CH2) b-
-n-CsH, -n-CsH,
D>- D> -
-ch2ch=ch2 -ch2ch = ch2
-ch2-<g)-ç -ch2- <g) -ç
Vch2 Vch2
-ch. -ch.
r(ôy~- r (ôy ~ -
Cl Cl
-ch2-c=ch -ch2-c = ch
~<Q>-och, ~ <Q> -och,
ch.,-ch=ch, -ch2ch=ch„ ch., - ch = ch, -ch2ch = ch "
thf thf thf thf thf thf thf thf thf thf thf thf thf thf thf thf thf thf
Äther ether
Äther ether
Äther ether
Äther ether
Äther Äther Äther thf Ether ether ether thf
Äther thf thf thf thf thf thf Äther ch2c12 Äther Ether thf thf thf thf thf thf ether ch2c12 ether
118-121 118-121
209-211 209-211
182,5-185 182.5-185
118-120 118-120
120,5-123,5 120.5-123.5
197-198 197-198
148-150 148-150
175-176 175-176
147-149 147-149
219-221 219-221
109-111 109-111
122-125 279-283 122-125 279-283
137-139 128-130 94-96 137-139 128-130 94-96
Öl oil
140-154 140-154
103-106 66-69 103-106 66-69
125-129 125-129
101-103 101-103
123-127 123-127
137-144 188-189 223-226 69-72 137-144 188-189 223-226 69-72
11 11
TABELLE I (Fortsetzung) TABLE I (continued)
619704 619704
Y Y
Z Z
ri' ri '
X X
r» r »
r2 r2
Reaktions-läsungsmittel Reaction solvent
Schmelzpunkt °C Melting point ° C
h h h h
h H
S S
-ch3 -ch3
-och3 -och3
ch2c12 ch2c12
74-77 74-77
h h h h
h H
0 0
h H
-oc2h5 -oc2h5
ch2ci2 ch2ci2
90-94 90-94
h h h h
h o h o
h H
-och2-ch=ch2 -och2-ch = ch2
ch2ci2 ch2ci2
70-73 70-73
h h h h
h H
0 0
Cyclohexyl Cyclohexyl
-oh ch2ci2 -oh ch2ci2
180-181 180-181
h H
H H
H H
o O
H H
-O-n-C0H1B -O-n-C0H1B
Äther ether
54-57 54-57
H H
H H
H H
o O
-ch(ch3)2 -ch (ch3) 2
-oh ch2c12 -oh ch2c12
113-116 113-116
H H
H H
H H
0 0
-ch2-ch= -ch2-ch =
ch2 -CHz-ch = ch2 ch2 -CHz-ch = ch2
Äther ether
69-72 69-72
-ch3 -ch3
H H
H H
o h o h
-c,h5 -c, h5
thf thf
209-211 209-211
-ch3 -ch3
H H
H H
o O
H H
-2-c4h9 -2-c4h9
thf thf
181-184 181-184
-ch3 -ch3
H H
H H
s s
H H
-c2h5 -c2h5
thf thf
116-118,5 116-118.5
-ch3 -ch3
H H
H H
o O
H H
H H
h2o h2o
234,5-236,5 234.5-236.5
-cha h -cha h
H H
o O
H H
-n-C6Hj3 -n-C6Hj3
thf thf
111-121 111-121
H H
-ch3 -ch3
H H
o < o <
H H
H H
h2o h2o
225-227 225-227
H H
-ch3 -ch3
h s h s
H H
-c2h0 -c2h0
thf thf
121-125 121-125
H H
-ch3 -ch3
H H
o O
H H
-2-c4H<i thf -2-c4H <i thf
197-198 197-198
H H
-ch3 -ch3
H H
0 0
h H
-n-CßHM -n-CßHM
thf thf
148-150 148-150
-ch3 -ch3
-ch3 -ch3
H H
s s
H H
-C2H5 -C2H5
thf thf
153-157 153-157
-ch3 -ch3
-ch3 -ch3
H H
o O
H H
-2-c4h0 -2-c4h0
thf thf
181-183,5 181-183.5
-ch3 -ch3
-ch3 -ch3
H H
o O
H H
-®-Cl thf -®-Cl thf
203-209 203-209
-ch3 -ch3
-cha -cha
H H
o O
H H
H H
h2o h2o
233-237 233-237
H H
H H
H H
o O
-(ch2)2-n-(ch2)2- - (ch2) 2-n- (ch2) 2-
1 1
Äther ether
110-113 110-113
1 1
co2c2h5 co2c2h5
h H
H H
H H
o O
H H
-n-QH;, -n-QH ;,
ch2c12 ch2c12
159-161 159-161
H H
H H
H H
o O
H H
-chocn thf -chocn thf
179-181 179-181
H H
H H
H H
0 0
h H
-ch2-ch2-och3 -ch2-ch2-och3
Äther ether
142-144 142-144
H H
H H
H H
o O
H H
-ch2ch2-s-ch3 -ch2ch2-s-ch3
Äther ether
128-130 128-130
H H
H H
H H
s s
-(cH2)2^ ^(ch2}2" - (cH2) 2 ^ ^ (ch2} 2 "
.c .c
Äther ether
235-238 235-238
>-c6H5 > -c6H5
HN ' HN '
H H
H H
H H
o O
H H
ri ri
Äther ether
183-185 183-185
H H
H H
H H
o O
-ch8 -ch8
-ch2-c=ch -ch2-c = ch
Äther ether
105-108 105-108
H H
H H
H H
0 0
H H
-NH-c02chs -NH-c02chs
Äther ether
183-186 183-186
H H
H H
H H
0 0
H H
ch,ci2 ch, ci2
171-172 171-172
619704 619704
12 12
TABELLE I (Fortsetzung) TABLE I (continued)
y z Y Z
ri" ri "
x r3 x r3
r2 r2
Reaktionslösungsmittel Reaction solvent
Schmelzpunkt °c h Melting point ° c h
h h h h
0 0
h H
-<Ô)-C1 - <Ô) -C1
ch2c12 ch2c12
234-237 234-237
h h h h
h o h o
h H
-CH2-Ç1 -CH2-Ç1
Äther ether
195-197 195-197
h h h h
h H
0 0
-ch2-c=ch -ch2-c = ch
-ch2-c=ch -ch2-c = ch
Äther ether
118-120 118-120
h h h h
h H
0 0
h H
"CH2"{2)Î "CH2" {2) Î
ch2cl2 ch2cl2
201-204 201-204
h h h h
h H
0 0
h H
-ch0-/0S -ch0- / 0S
ch2ci2 ch2ci2
192-195 192-195
H H
H H
H H
H H
H H
H H
H H
h h h h
h h h h
h h h h
h H
H H
H H
H H
H H
H H
H H
H H
n- n-
O O
H H
-ch. -ch.
r®- r®-
0CH- 0CH-
CH2CL CH2CL
O O
-(ch2)2-n-(ch2)2- - (ch2) 2-n- (ch2) 2-
CHoCL CHoCL
"o "O
O O
o o o o
o o o o
H H
H H
H H
H H
H H
îci-i3 îci-i3
(oy$ o (oy $ o
-<o>-c - <o> -c
CH„ CH "
3 3rd
-Cl -Cl
• Cl- • Cl-
. -^)-0CH3 : och3 . - ^) - 0CH3: och3
~<ô> oc2h5 ~ <ô> oc2h5
CHoCL CHoCL
CH2C12 CH2C12
CH2Cl2 CH2Cl2
CH,Clo CH, Clo
CH,CL CH, CL
188-191 188-191
h h h h
h o h o
h H
-ch^-cf3 -ch ^ -cf3
ch2ci2 ch2ci2
208-211 208-211
h h h h
h o h o
-ch3 -ch3
-CH2cbh5 -CH2cbh5
ch2ci2 ch2ci2
68-70 68-70
h h h h
h o h o
h H
-t-Butyl ch2ci2 -t-butyl ch2ci2
187-192 187-192
h h h h
h o h o
h H
-C32-(Ô)-C1 " -C32- (Ô) -C1 "
ch2cl ch2cl
216-217 216-217
h h h h
h o h o
h H
-ch2ch(och3)2 -ch2ch (och3) 2
ch2cl ch2cl
125-128 125-128
h h h h
h o h o
h H
<1 <1
CH2Ck CH2Ck
175-178 175-178
h h h h
h o h o
-CH2cch5 -CH2cch5
-ch2c=ch ch2c12 -ch2c = ch ch2c12
112-115 112-115
129-133 129-133
231-234 231-234
241-242,5 241-242.5
242-245 242-245
200-204 200-204
221-225 221-225
13 13
619704 619704
TABELLE I (Fortsetzung) TABLE I (continued)
r,' r, '
R, R,
r, r,
Reaktions- Schmelzpunkt lösungsmittel °C Reaction melting point solvent ° C
h h h h h h h h
h h h h h h h h h h h h h h h h
O O
O O O O
O O
h o h o
H H
-CH,CRH5 -CH, CRH5
h h h h
h o -0 h o -0
-0-oc4h3 -0-oc4h3
-OH -OH
-<2>( - <2> (
-o/cà -o / cà
-oh chocl chocl ch,cl -oh chocl chocl ch, cl
183-186 183-186
CH2C12 121-123 CH2C12 121-123
CH2C12 143-146 CH2C12 143-146
223-226 223-226
CH2C12 159-161 CH2C12 159-161
131-133 131-133
Beispiel 12 Example 12
Herstellung von 4,5,6,7-Tetrahydro-7-oxobenzo-[bJ-thien--4-yl-isocyanat und -harnstoff Preparation of 4,5,6,7-tetrahydro-7-oxobenzo [bJ-thien - 4-yl isocyanate and urea
Man bewirkt die Umwandlung des 4,5,6,7-Tetrahydro-7--oxobenzo-[b]-thiophen-4-amin-hydrochlorids in das 4,5,6,7--Tetrahydro-7-oxobenzo-[b]-thien-4-yl-isocyanat dadurch, dass man eine Mischung aus Toluol und dem Hydrochlorid zum Rückfluss erhitzt und Phosgen einleitet. Nachdem die Mischung weniger trüb geworden ist, wird sie abgekühlt und filtriert. Durch Eindampfen des Filtrats erhält man das rohe 4,5,6,7-Tetrahydro-7-oxobenzo-[b]-thien-4-yl-isocyanat, dessen IR-Spektrum ein Maximum bei 2250 cm-1 zeigt. The 4,5,6,7-tetrahydro-7-oxobenzo- [b] -thiophene-4-amine hydrochloride is converted into 4,5,6,7-tetrahydro-7-oxobenzo- [b ] -thien-4-yl isocyanate by heating a mixture of toluene and the hydrochloride to reflux and introducing phosgene. After the mixture has become less cloudy, it is cooled and filtered. Evaporation of the filtrate gives the crude 4,5,6,7-tetrahydro-7-oxobenzo [b] thien-4-yl isocyanate, the IR spectrum of which shows a maximum at 2250 cm-1.
Durch Zugabe einer Lösung von Ammoniak in Methanol zu diesem Isocyanat erhält man 4,5,6,7-Tetrahydro-oxo-benzo- [b] -thien-4-yl-harnstoff. Adding a solution of ammonia in methanol to this isocyanate gives 4,5,6,7-tetrahydro-oxo-benzo [b] thien-4-yl urea.
Beispiel 13 Example 13
Die im folgenden angegebenen Verbindungen erhält man durch Umsetzen von 4,5,6,7-Tetrahydro-7-oxobenzo-[b]--thien-4-yl-isocyanat mit den entsprechenden Aminen in inerten Lösungsmitteln nach der in Beispiel 11 angegebenen Methode. The compounds indicated below are obtained by reacting 4,5,6,7-tetrahydro-7-oxobenzo [b] thien-4-yl isocyanate with the corresponding amines in inert solvents by the method given in Example 11 .
S /r3 S / r3
nh-c-n nh-c-n
NR-> NR->
30 30th
35 35
45 45
50 50
Amine Amines
R3 R3
Produkt R2 Product R2
Smp. (°c) Mp (° c)
nh2-och,3 nh2-och, 3
h H
-och3 -och3
185-188,5 185-188.5
nh2-oh h nh2-oh h
-oh -Oh
— -
ch,nh-oh ch, nh-oh
-ch3 -ch3
-oh -Oh
163-165,5 163-165.5
chanh-ocha chanh-ocha
-CHj -CHj
-och3 -och3
126-129 126-129
ch2 = ch-ch2-nh2 ch2 = ch-ch2-nh2
h H
-ch,-ch = ch;, -ch, -ch = ch ;,
171-174 171-174
CH=c-cho-nh2 CH = c-cho-nh2
h H
-ch2-c=ch -ch2-c = ch
197-199 197-199
(ch3)2nh (ch3) 2nh
-cha -cha
-cha. -cha.
195-197 195-197
c0h5ch2nh2 c0h5ch2nh2
h H
-CHo-cuh5 -CHo-cuh5
— -
c2h5nh2 c2h5nh2
h H
-c2h5 -c2h5
188-190 188-190
n-C4HnNH2 n-C4HnNH2
H H
-n-C4H9 -n-C4H9
— -
o O
Ii II
o O
II II
II II
ch3c-nh2 ch3c-nh2
H H
II II
-c-ch3 -c-ch3
— -
60 60
(ö)-ch2-nh2 h -ch2 (ö) -ch2-nh2 h -ch2
t[o!Lcn2-NH2 H ~ t [o! Lcn2-NH2 H ~
ch2 -ö ch2 -ö
65 65
ch,, ch ,,
-CH-NH.. -CH-NH ..
h H
CH, CH,
-CH(CHB)2 -CH (CHB) 2
198-200 198-200
619704 619704
14 14
Versuch 1 Trial 1
Die folgenden Untersuchungen dienen der Bewertung der Wachstumsförderungseigenschaften von 4,5,6,7-Tetrahydro-benzo-[b]-thien-4-yl-harnstoffen gegenüber Küken. The following studies serve to evaluate the growth promoting properties of 4,5,6,7-tetrahydro-benzo- [b] -thien-4-yl-ureas against chicks.
Bei diesen Untersuchungen verwendet man Küken mit einem Alter von 1 Tag, die man in geheizte Käfige einbringt und ad libitum mit Futter und Wasser versorgt. Bei jeder Untersuchung verwendet man 5 männliche und 5 weibliche Küken pro Käfig und pro Behandlung 3 Käfige. Die Behandlung besteht aus einem Grundfutter, das mit 1, 3 oder 9 ppm der zu untersuchenden Verbindung versetzt wird. Die Küken werden zu Beginn und gegen Ende der Untersuchung gewogen. Der Futterverbrauch wird während der Untersuchungsperiode bestimmt, die 13 Tage vom Beginn des Tages an, an dem die Küken 1 Tag alt sind, dauert. Die Zusammensetzung des verwendeten Grundfutters und die erhaltenen Ergebnisse sind im folgenden angegeben. In these studies, chicks 1 day old are used, which are placed in heated cages and supplied with food and water ad libitum. In each examination, 5 male and 5 female chicks are used per cage and 3 cages per treatment. The treatment consists of a basic feed, which is mixed with 1, 3 or 9 ppm of the compound to be examined. The chicks are weighed at the beginning and at the end of the examination. Feed consumption is determined during the study period, which is 13 days from the start of the day the chicks are 1 day old. The composition of the basic feed used and the results obtained are given below.
Vitamin-Vormischung für 1 Tonne Vitamin premix for 1 ton
Küchengrundfutter gemahlener gelber Mais Sojabohnenölmehl (49%) Menhaden-Fischmehl (60%) Maisglutenmehl (60%) entwässertes Luzernenmehl (17%) stabilisiertes Fett Dikalziumphosphat vermahlener Kalkstein Natriumchlorid Tra-Min Nr. 3* Vitamin-Vormischung* * Basic kitchen food ground yellow corn Soy flour (49%) Menhaden fish meal (60%) Corn gluten meal (60%) Dehydrated alfalfa meal (17%) Stabilized fat Dicalcium phosphate ground limestone Sodium chloride Tra-Min No. 3 * Vitamin premix * *
53,45% 28,0 5,0 5,0 2,0 4,0 1,2 0,5 0,3 0,05 0,5 53.45% 28.0 5.0 5.0 2.0 4.0 1.2 0.5 0.3 0.05 0.5
100,00 100.00
10 10th
15 15
20 20th
25 25th
30 30th
35 35
40 40
D,L-Methionin D, L-methionine
453,6 g 453.6 g
BHT BHT
113,6 113.6
Vitamin A (30 000 Einheiten/g) Vitamin A (30,000 units / g)
100,0 100.0
Vitamin D;i (200000 Einheiten/g) Vitamin D; i (200000 units / g)
5,0 5.0
Vitamin E (44093 Einheiten/kg) Vitamin E (44093 units / kg)
45,5. 45.5.
Riboflavin Riboflavin
4,0 4.0
Niacinamid Niacinamide
25,0 25.0
Kalziumpantothenat Calcium pantothenate
8,0 8.0
Vitamin K (Menadion) Vitamin K (menadione)
1,0 1.0
Folsäure (Parvo [10%]) Folic acid (parvo [10%])
13,0 13.0
Cholinchlorid (50%) Choline chloride (50%)
908,0 908.0
Vitamin B12 (Proferm, 44 mg/kg) Vitamin B12 (Proferm, 44 mg / kg)
227,0 227.0
Maisöl Corn oil
50,0 50.0
feinvermahlener Mais finely ground corn
2582,4 4536,0 2582.4 4536.0
* Tra-Min Nr. 3 * Tra-Min No. 3
0,454 kg/t ergeben Result in 0.454 kg / t
Mangan 12,50% Manganese 12.50%
62,5 ppm 62.5 ppm
Eisen 6,00% Iron 6.00%
30,0 30.0
Zink 5,00% Zinc 5.00%
25,0 25.0
Kupfer 0,65 % Copper 0.65%
3,25 3.25
Jod 0,35% Iodine 0.35%
1,75 1.75
Kobalt 0,25% Cobalt 0.25%
1,25 1.25
Kalzium 15,30% min. Calcium 15.30% min.
18,35% max. 18.35% max.
Kükentest mittlere Gewichtszunahme der Küken nach 13 Tagen (g) Chick test mean chick weight gain after 13 days (g)
Behandlung treatment
Dosis (ppm) Dose (ppm)
1928 1928
1929 1929
Experiment 1900 1 931 Experiment 1900 1 931
Durchschnitt prozentuale Verbesserung Average percentage improvement
1. 1.
Kontrolle control
— -
189 189
175 175
180 180
188 188
183 183
— -
2. 2nd
4,5,6,7-Tetrahydro- 4,5,6,7-tetrahydro-
1 1
181 181
193 193
182 182
200 200
189 189
3,3 3.3
' '
3. 3rd
benzo-[b]-thien-4- benzo- [b] thien-4-
3 3rd
199 199
186 186
197 197
198 198
195 195
6,6 6.6
4. 4th
-yl-harnstoff -yl urea
9 9
190 190
198 198
191 191
191 191
193 193
5,5 5.5
mittlere Gewichtszunahme in kg/kg Futter während der 13 Tage mean weight gain in kg / kg of feed during the 13 days
1. 1.
Kontrolle control
— -
1,54 1.54
1,52 1.52
1,46 1.46
1,48 1.48
1,50 1.50
— -
2. 2nd
4,5,6,7-Tetrahydro- 4,5,6,7-tetrahydro-
1 1
1,48 1.48
1,45 1.45
1,49 1.49
1,44 1.44
1,46 1.46
2,7 2.7
3. 3rd
benzo- [ b] -thien-4- benzo- [b] thien-4-
3 3rd
1,47 1.47
1,40 1.40
1,44 1.44
1,40 1.40
1,43 1.43
4,7 4.7
4. 4th
. -yl-harnstoff . -yl urea
9 9
1,45 1.45
1,45 1.45
1,46 1.46
1,40 1.40
1,44 1.44
4,0 4.0
15 15
619704 619704
Versuch 2 Trial 2
Wachstumsförderung und Futterwirkungsgradbewertungen bei Schafen, die ein die zu untersuchende Verbindung enthaltendes Implantat verabreicht bekommen haben Growth promotion and feed efficiency ratings in sheep that have received an implant containing the compound to be investigated
Um die Wirkung einer 4,5,6,7-Tetrahydrobenzo-[b]-thien--4-yI-harnstoff-Verbindung auf Schafe zu untersuchen, werden Wether-Lämmer statistisch in Gruppen von 6 in Gehege aufgeteilt. Die Schafe werden gewogen und ad libitum mit Futter und Wasser versorgt. Das Futter wird täglich gewogen, und das nicht verbrauchte Futter des Vortags wird gesammelt und gewogen. Die Testlämmer werden mit dem gleichen.nicht mit dem Wirkstoff versetzten Futter wie die Kontrolltiere versorgt, bekommen jedoch ein oder mehrere subkutane Implantate in die Basis der Ohren verabreicht, die die zu untersuchende Verbindung enthalten. Die Formulierung des verwendeten Implantats ist im folgenden angegeben. Nach Ablauf der sechswöchigen Behandlungszeit werden die Lämmer erneut gewogen, und es wird das gesamte verbrauchte Futter berechnet. In order to investigate the effect of a 4,5,6,7-tetrahydrobenzo- [b] -thien-4-yI-urea compound on sheep, Wether lambs are statistically divided into groups of 6 in enclosures. The sheep are weighed and provided with food and water ad libitum. The feed is weighed daily and the unused feed from the previous day is collected and weighed. The test lambs are provided with the same non-drug-containing feed as the control animals, but are given one or more subcutaneous implants in the base of the ears, which contain the compound to be examined. The formulation of the implant used is given below. After the six-week treatment period, the lambs are weighed again and the total feed consumed is calculated.
Bei diesen Untersuchungen werden pro Behandlung sechs Gruppen â sechs Lämmer verwendet, von denen jedes Tier etwa 11 bis .105 mg der untersuchenden Verbindung verabreicht bekommt. In these studies, six groups of six lambs are used per treatment, of which approximately 11 to .105 mg of the investigating compound is administered to each animal.
In der Tabelle II sind die mittleren Gewichtszunahmen im Verlaufe der sechs Wochen angegeben, während in der Tabelle III die Gewichtszunahme in kg/kg Futter angegeben ist. Aus diesen Werten kann ersehen werden, dass die Lämmer, denen 11 mg oder 99 mg der zu untersuchenden Verbindung implantiert worden ist, 6 Wochen nach der Implantation gegenüber den nicht-behandelten Vergleichstieren eine Gewichtszunahme von etwa 10% zeigen. Die Futter-ausnützung während dieser Periode gegenüber den nicht-be-handelten Vergleichstieren wird ebenfalls um etwa 5% verbessert. Table II shows the mean weight gains over the six weeks, while Table III shows the weight gains in kg / kg of feed. From these values it can be seen that the lambs who have been implanted with 11 mg or 99 mg of the compound to be examined show a weight gain of about 10% compared to the untreated control animals 6 weeks after the implantation. The feed utilization during this period compared to the untreated control animals is also improved by about 5%.
Lammfutter Lamb feed
«/» «/»
vermahlene Maiskolben ground corn cobs
15,0 15.0
vermahlener gelber Mais ground yellow corn
48,0 48.0
Sojabohnenölmehl (49%) Soy flour (49%)
10,0 10.0
entwässertes Luzernenmehl dehydrated alfalfa flour
15,0 15.0
Melasse molasses
10,0 10.0
jodiertes Salz iodized salt
0,5 0.5
Dikalziumphosphat Dicalcium phosphate
1,0 1.0
Vormischung Premix
0,5 0.5
100,0 100.0
Vormischung für 1 Tonne g Premix for 1 ton g
Tra-Min Nr. 3«1' Tra-Min No. 3 «1 '
454 454
Vitamin A (30 000 Einheiten/g) Vitamin A (30,000 units / g)
133 133
Vitamin D3 (200 000 Einheiten/g) Vitamin D3 (200,000 units / g)
5 5
Maisöl Corn oil
100 100
gemahlener Mais ground corn
3848 3848
4540 4540
(1)Tra-Min Nr. 3 = (1) Tra-Min No. 3 =
V# V #
Kalzium calcium
21,00 21.00
Mangan manganese
12,50 12.50
Eisen iron
6,00 6.00
Zink zinc
5,00 5.00
Kupfer copper
0,65 0.65
Jod iodine
0,35 0.35
Kobalt cobalt
0,25 0.25
Pellet-Implantat Pellet implant
4,5,6,7-Tetrahydrobenzo-[b]-thien-4-yl-harnstoff 4,5,6,7-tetrahydrobenzo- [b] thien-4-yl urea
11,0 mg 11.0 mg
Glyceryl-12-hydroxystearat Glyceryl 12-hydroxystearate
10,50 mg 10.50 mg
Magnesiumstearat Magnesium stearate
0,50 mg 0.50 mg
22,00 mg 22.00 mg
5 5
10 10th
15 15
20 20th
25 25th
30 30th
35 35
40 40
45 45
50 50
55 55
60 60
65 65
619704 619704
16 16
TABELLE II TABLE II
mittlere Gewichtszunahme im Verlaufe von 6 Wochen, kg/Lamm mean weight gain over 6 weeks, kg / lamb
Behandlung treatment
Anzahl der Arzneimittelimplantate (a) Number of drug implants (a)
1 1
Wiederholungen 3 4 5 Repetitions 3 4 5
Mittel medium
Kontrolle control
0 0
8,50 8.50
8,70 8.70
9,93 9.93
6,50 6.50
7,03 7.03
6,75 6.75
7,90 7.90
4,5,6,7-Tetrahydrobenzo- 4,5,6,7-tetrahydrobenzo
1 1
11,25 11.25
9,32 9.32
9,20 9.20
8,63 8.63
8,05 8.05
6,68 6.68
8,86 8.86
-[b]-thien-4-yl-harnstoff - [b] -thien-4-yl urea
9 9
10,83 10.83
9,60 9.60
8,75 8.75
7,20 7.20
8,53 8.53
7,20 7.20
8,69 8.69
(a) durchschnittliches Gewicht: jeweils 22 mg (a) Average weight: 22 mg each
Zusammensetzung: 50% Wirkstoff 4- 50% Trägermaterial Composition: 50% active ingredient 4- 50% carrier material
TABELLE III TABLE III
durchschnittliche Gewichtszunahme in kg/kg Futter pro Gehege average weight gain in kg / kg feed per enclosure
Behandlung treatment
Anzahl der Arzneimittelimplantate (a) Number of drug implants (a)
1 1
2 2nd
Wiederholungen 3 4 5 Repetitions 3 4 5
6 6
Mittel medium
Kontrolle control
0 0
7,88 7.88
6,77 6.77
7,41 7.41
8,82 8.82
9,18 9.18
8,16 8.16
8,04 8.04
4,5,6,7-Tetrahydro- 4,5,6,7-tetrahydro-
1 1
6,63 6.63
6,58 6.58
7,41 7.41
8,21 8.21
8,05 8.05
8,49 8.49
7,57 7.57
-[b]-thien-4-yl-harnstoff - [b] -thien-4-yl urea
9 9
6,51 6.51
6,75 6.75
7,80 7.80
8,38 8.38
7,56 7.56
7,97 7.97
7,49 7.49
(a) durchschnittliches Gewicht: jeweils 22 mg (a) Average weight: 22 mg each
Zusammensetzung: 50% Wirkstoff + 50% Trägermaterial Composition: 50% active ingredient + 50% carrier material
Versuch 3 Trial 3
Untersuchung der wachstumsregulierenden Wirkung an Mäusen Investigation of the growth regulating effect on mice
Man erhält die weiblichen Mäuse (CFI) von der Car-worth-Farm mit einem Alter von 6 Wochen. Sie werden in Gruppen zu 10 Tieren in Käfigen gehalten, die sich in klimatisierten Räumen [22,2 bis 24,4°C (72 bis 76°F)] befinden, die automatisch während 14 Stunden beleuchtet und während 10 Stunden dunkel gehalten werden. Die bei diesen Untersuchungen verwendete Grunddiät ist ein Purina-Laborato-riumsfutter (Purina Laboratory Chow), der im folgenden angegebenen Zusammensetzung, das ad libitum gereicht wird, ebenso wie Wasser, das ebenfalls ad libitum zugeführt wird. The female mice (CFI) are obtained from the car worth farm at 6 weeks of age. They are caged in groups of 10 animals that are in air-conditioned rooms [22.2 to 24.4 ° C (72 to 76 ° F)] that are automatically lit for 14 hours and kept dark for 10 hours. The basic diet used in these studies is a Purina Laboratory Chow (Purina Laboratory Chow), the composition given below, which is given ad libitum, as well as water, which is also added ad libitum.
13 Tage nach der Ankunft werden die Mäuse in Gruppen zu 10 Tieren gewogen und statistisch für verschiedenen Behandlungen ausgewählt. Die Konzentration der verschiedenen Verbindungen im Futter ist in den folgenden Tabellen angegeben. 12 Tage später werden die Mäuse erneut gewogen und das Experiment beendet. Bei jeder Untersuchung werden mindestens 3 Käfige mit unbehandelten Kontrollmäusen (30 Mäuse) verwendet. Die Untersuchungsergebnisse sind in der folgenden Tabelle IV angegeben, in der die Werte für die prozentuale Gewichtszunahme gegenüber den Kontrolltieren aufgeführt sind. Thirteen days after arrival, the mice are weighed in groups of 10 animals and statistically selected for various treatments. The concentration of the various compounds in the feed is given in the following tables. The mice are weighed again 12 days later and the experiment is ended. At least 3 cages with untreated control mice (30 mice) are used in each examination. The test results are given in the following Table IV, which shows the values for the percentage weight gain compared to the control animals.
Im folgenden ist eine Beschreibung des Futters angegeben, in dem die wachstumsfördernden Verbindungen zugesetzt werden. The following is a description of the feed in which the growth promoting compounds are added.
Futter Lining
Garantierte Analysenwerte: Guaranteed analytical values:
Rohes Protein, nicht weniger als 23,0% Raw protein, not less than 23.0%
rohes Fett, nicht weniger als 4,5% raw fat, not less than 4.5%
rohe Fasern, nicht mehr als 6,0% raw fibers, not more than 6.0%
Bestandteile: Components:
Fleisch- und Knochenmehl, getrocknete Magermilch, Weizenkeimmehl, Fischmehl, Tierlebermehl, getrocknete ausgelaugte Rübenschnitzel, vermahlener stranggepresster Mais, 35 Haferschrotmehl, Sojabohnenmehl, entwässertes Luzernenmehl, Rohrzuckermelasse, mit Butylhydroxyanisol konserviertes tierisches Fett, Vitamin B12-Zusatz, Kalziumpanto-thenat, Cholinchlorid, Folsäure, Riboflavinzusatz, getrocknete Bierhefe, Thiamin, Niacin, Vitamin A-Zusatz, D-akti-40 viertes Pflanzensterin, Vitamin E-Zusatz, Kalziumcarbonat, Dikalziumphosphat, jodiertes Salz, Eisen(III)-ammonium-citrat, Eisenoxid, Mangan(II)-oxid, Kobaltcarbonat, Kupferoxid und Zinkoxid. Meat and bone meal, dried skimmed milk, wheat germ meal, fish meal, animal liver meal, dried leached beet pulp, ground extruded maize, 35 oatmeal meal, soybean meal, dehydrated alfalfa meal, cane sugar molasses, animal fat then preserved with butylated hydroxyanisole, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium choline additive, potassium chinoid additive, potassium choline additive, potassium choline, additive, animal fat, calcium chloride, folium chloride, added to cholesterol; , Riboflavin additive, dried brewer's yeast, thiamine, niacin, vitamin A additive, D-acti-40 fourth plant sterol, vitamin E additive, calcium carbonate, dicalcium phosphate, iodized salt, iron (III) ammonium citrate, iron oxide, manganese (II) -oxide, cobalt carbonate, copper oxide and zinc oxide.
Asche, nicht mehr als Ash, no more than
9,0% 9.0%
17 17th
619704 619704
TABELLE III TABLE III
Wirkung von 4,5,6,7-Tetrahydrobenzo[b]-thien-4-yl-Harnstoffen als das Wachstum von Tieren fördernde Mittel. Die an Mäusen bestimmten Werte sind als prozentuale Gewichtszunahme gegenüber den Kontrolltieren angegeben. Effect of 4,5,6,7-tetrahydrobenzo [b] thien-4-yl ureas as animal growth promoting agents. The values determined in mice are given as a percentage weight gain compared to the control animals.
W /r2 W / r2
n-c-n n-c-n
^3 ^ 3
Dosis in ppm im Futter Dose in ppm in the feed
X X
Y Y
Z Z
Ri' Ri '
ro ro
R* R *
Gewichtszunahme gegenüber Kontrolltieren in % Weight gain compared to control animals in%
50 50
0 0
h h h h
h h h h
h H
50,1 50.1
400 400
o h o h
h h h h
h h h h
119,6 119.6
50 50
0 0
h h h h
h h h h
-ch3, -ch3,
61,8 61.8
200 200
o h o h
h h h h
h h h h
134,2 134.2
50 50
o h o h
h h h h
h H
-CÄ -CÄ
40,3 40.3
200 200
o h o h
h h h h
h H
-c2h5 -c2h5
87,6 87.6
400 400
0 0
h h h h
h H
-oh -Oh
-ch3, -ch3,
49,6 49.6
400 400
o h o h
h h h h
-ocha h -ocha h
68,6 68.6
400 400
0 0
h h h h
h H
■ch» ■ ch »
-ch8 -ch8
55,1 55.1
400 400
0 0
h h h h
h H
-oh h -oh h
102,0 102.0
400 400
0 0
h h h h
h H
-ochs -Oh
-ch, -ch,
106,8 106.8
400 400
o O
H H
h H
H H
H H
-ch(ch3)2 -ch (ch3) 2
88,0 88.0
400 400
o h o h
h h h h
-CH,CHHg> -CH, CHHg>
H H
72,3 72.3
400 400
o h o h
H H
H H
-ch2-<Ô> -ch2- <Ô>
h H
32,4 32.4
400 400
s s
H H
H H
h h h h
-c2h5 -c2h5
54,6 54.6
400 400
o O
Br Br
H H
h H
H H
h H
76,3 76.3
400 400
o O
Cl h Cl h
h h h h
h H
4,8 4.8
400 400
o h o h
h h h h
-n-C0h13 -n-C0h13
h H
14,5 14.5
400 400
0 0
-cha h -cha h
h h h h
h H
7,6 7.6
400 400
s h s h
h h h h
-ch3, -ch3,
h H
88,5 88.5
400 400
o h o h
h h h h
h H
(linksdrehendes Isomeres) (left-turning isomer)
h H
122,5 122.5
400 400
o h o h
h h h h
-ch2ch=ch2 -ch2ch = ch2
h H
48,4 48.4
400 400
o h o h
H H
h H
H H
-ch3 -ch3
134 134
400 400
o O
H H
H H
H H
H H
-c2h5 -c2h5
87,6 87.6
400 400
o h o h
H H
H H
H H
-CH(ch3)ü -CH (ch3) ü
88 88
400 400
o O
H H
H H
h n-Hexyl h h n-hexyl h
14,5 14.5
400 400
o O
H H
H H
H H
H H
-CH2cuh5 -CH2cuh5
32,4 32.4
400 400
o O
H H
H H
H H
H H
-ch2CH,cch5 -ch2CH, cch5
72,3 72.3
619704 619704
18 18th
TABELLE III (Fortsetzung) TABLE III (continued)
Dosis in ppm im Futter Dose in ppm in the feed
X X
Y Y
Z Z
Ri' Ri '
R2 R2
Gewichtszunahme gegenüber Kontrolltieren in % Weight gain compared to control animals in%
400 400
S S
h h h h
h h h h
-c2h5 -c2h5
54,6 54.6
400 400
0 0
h h h h
h H
-ch, -ch,
-ch3 -ch3
55,1 55.1
400 400
0 0
h h h h
h H
-ch2-ch2-o-ch2-ch2- -ch2-ch2-o-ch2-ch2-
9,9 9.9
400 400
0 0
h h h h
h h h h
-ch2-ch=ch.. -ch2-ch = ch ..
48,4 48.4
400 400
s h s h
h h h h
h H
1 1
-ch3 -ch3
88 88
400 400
0 0
h h h h
h itju h h itju h
43 43
400 400
0 0
h h h h
h H
-ch2-ch2- -ch2-ch2-
ch2-ch2- ch2-ch2-
18 18th
400 400
0 0
h h h h
h H
-n-Butyl -n-butyl
-n-Butyl -n-butyl
6 6
400 400
s h s h
h h h h
h h h h
11 11
400 400
s h s h
h h h h
H H
15 15
400 400
s s
H H
H H
H H
h H
-n-Butyl -n-butyl
75 75
400 400
0 0
H H
H H
H H
-ch2-ch2-oh -ch2-ch2-oh
H H
3 3rd
400 400
s s
H H
H H
H H
-n-c8H17 -n-c8H17
H H
16 16
400 400
s s
H H
H H
H H
—^ - ^
H H
32 32
400 400
s s
H H
H H
H H
H H
-ch,-ch=ch -ch, -ch = ch
60 60
400 400
0 0
H H
H H
H H
H H
-ch2-c=ch -ch2-c = ch
82 82
Dosis in ppm v v 7 w ' w p Gewichtszunahme gegen- Dose in ppm v v 7 w 'w p
im Futter i s 2 über Kontrolltieren in % in feed i s 2 over control animals in%
200 200
o h o h
h h h h
-n-Butyl h -n-butyl h
25 25th
400 400
o h o h
h h h h
h H
-ch2cn -ch2cn
12 12
400 400
0 0
h h h h
h H
-CH2CH2^ yCH -CH2CH2 ^ yCH
2"CH2- 2 "CH2-
14 14
0 -•=f v 0 - • = f v
C6K5 C6K5
HN ' HN '
cv-\ cv- \
400 400
0 0
h h h h
h h h h
Kp)-01 Kp) -01
18 18th
400 400
0 0
h h h h
h H
-ch3, -ch3,
\ / \ /
-ch2c=ch -ch2c = ch
29 29
400 400
0 0
h h h h
h h h h
-nh-co2ch3 -nh-co2ch3
18 18th
400 400
0 0
h h h h
h h h h
-^5)—" och3 - ^ 5) - "och3
78 78
400 400
0 0
h h h h
h H
-ch2-ch=ch2 -ch2-ch = ch2
-ch2-ch=ch. -ch2-ch = ch.
4,0 4.0
400 400
0 0
h h h h
h h h h
-ch2-Ç -ch2-Ç
39 39
400 400
0 0
h h h h
h H
-ch2-c=ch -ch2-c = ch
-cha-c=ch -cha-c = ch
27 27th
im ] in the ]
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
19 19th
619704 619704
TABELLE III (Fortsetzung) TABLE III (continued)
X X
Y Y
Z Z
Ri o Ri o
H H
H H
H H
0 0
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
H H
H H
H H
o O
II II
H H
H H
0 0
H H
H H
H H
o O
H H
H H
H H
n > p -d Gewichtszunahme gegen n> p -d weight gain against
13 2 über Kontrolltieren in % 13 2 over control animals in%
h "ch2-^j 48 h "ch2- ^ j 48
H "TV-V 21 H "TV-V 21
16 16
-r@-Cl -r @ -Cl
-CH2-@-OCH3 -CH2 - @ - OCH3
-CHff) - . -CH£<£>- • -CHff) -. -CH £ <£> - •
clth, clth,
-ch2-<o)-ci -tCH2)3-(o) -ch2- <o) -ci -tCH2) 3- (o)
0- 0-
o h h h o h h h h o h h h h o h h h o h h h h o h h h h
-<ö)-oc2h5 - <ö) -oc2h5
O O
H H
H H
H H
H H
-\2/~ 0-n - \ 2 / ~ 0-n
O O
H H
H H
H H
H H
-OH -OH
O O
H H
H H
H H
H H
-OCH, -OCH,
41 41
46 46
-(ch2)2-n-(ch2)2- 3 - (ch2) 2-n- (ch2) 2-3
-ch2cf3 19 -ch2cf3 19th
1 1
-chx0h5 14 -chx0h5 14
-ch2-ch(och3)2 22 -ch2-ch (och3) 2 22
31 31
-ch2-c=ch 30 -ch2-c = ch 30
— CCH2) 2 — N—(ch2> 2"" 24 l<0v0ch3 - CCH2) 2 - N— (ch2> 2 "" 24 l <0v0ch3
-@-U02 9 - @ - U02 9
o h h h h o h h h h
9 9
102,9 68,5 102.9 68.5
im. I in the. I.
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
400 400
20 20th
TABELLE III (Fortsetzung) TABLE III (continued)
Gewichtszunahme gegenüber Kontrolltieren in % Weight gain compared to control animals in%
o h o h
h h h h
-ch3 -ch3
-oh -Oh
49,6 49.6
o h o h
h h h h
-ch3 -ch3
-0ch3 -0ch3
106,8 106.8
s h s h
h h h h
-ch3 -ch3
-OCH3. -OCH3.
66 66
0 0
h h h h
h h h h
-oc2h3 -oc2h3
61 61
o h o h
h h h h
h H
-o-ch,-ch=ch2 -o-ch, -ch = ch2
5 5
0 0
h h h h
h rO h rO
-oh -Oh
19 19th
o h o h
h h h h
h H
-o-n-qjhjg, -o-n-qjhjg,
29 29
o h o h
h h h h
-CH(ch3)o -CH (ch3) o
-oh -Oh
32 32
o h o h
h h h h
-ctlca -ctlca
-oh -Oh
12 12
o O
Br h Br h
h h h h
h H
76,3 76.3
o O
Cl h Cl h
h h h h
h H
4,8 4.8
o O
-ch» -ch »
h h h h
h h h h
7,6 7.6
o O
-cha h -cha h
h H
-2-Butyl h -2-butyl h
2 2nd
o h o h
-ch3 -ch3
H H
H H
H H
26 26
0 0
H H
-ch3 -ch3
H H
H H
-n-Hexyl -n-hexyl
21 21st
o O
-chs -chs
-ch3 -ch3
H H
-2-Butyl -2-butyl
H H
3 3rd
o O
-ch3 -ch3
-ch3 -ch3
H H
H H
H H
0 0
21 21st
619704 619704
TABELLE IV TABLE IV
Wirksamkeit von Cycloalkano-[b]-thienylharnstoffverbindungen als das Wachstum von Tieren fördernde Mittel. Die an Mäusen bestimmten Versuchsergebnisse sind als prozentuale Gewichtszunahme gegenüber den Kontrolltieren angegeben. Efficacy of cycloalkano- [b] thienylurea compounds as animal growth promoters. The test results determined on mice are given as a percentage weight gain compared to the control animals.
Dosis in ppm Dose in ppm
im Futter Verbindung in the lining compound
Gewichtszunahme gegenüber den Kontrolltieren in % Weight gain compared to the control animals in%
400 400
nh-co-nh-r. nh-co-nh-r.
ch3 ch3 ch3 ch3
-CH., -CH.,
15 15
400 400
h-co-nh-r. h-co-nh-r.
400 400 400 400
400 400
400 50* 100* 200* 400* 400 50 * 100 * 200 * 400 *
nh-conh-r. nh-conh-r.
1jih-c0-nh-r o nh-co-nh-r2 1jih-c0-nh-r o nh-co-nh-r2
-ch3. -ch3.
39 39
h H
110 110
h H
99 99
-ch3 -ch3
41 41
-c2h5 -c2h5
40 40
h H
54 54
-ch2-o-chs -ch2-o-chs
10 10th
h H
134 134
h H
112 112
h H
108 108
h H
117 117
h H
105 105
' Pro Dosis wurden jeweils 5 Käfige zu 10 Mäusen untersucht. '5 cages of 10 mice were examined per dose.
v v
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43682774A | 1974-01-25 | 1974-01-25 | |
US43682674A | 1974-01-25 | 1974-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH619704A5 true CH619704A5 (en) | 1980-10-15 |
Family
ID=27031116
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH87775A CH619703A5 (en) | 1974-01-25 | 1975-01-24 | Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof |
CH1016678A CH619704A5 (en) | 1974-01-25 | 1978-09-29 | Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof |
CH1016878A CH619705A5 (en) | 1974-01-25 | 1978-09-29 | Process for the preparation of N-formyl-7-oxocyclohexano- or -8-oxocycloheptano[b]thiophene-4-amines |
CH1016778A CH619949A5 (en) | 1974-01-25 | 1978-09-29 | Process for the preparation of novel 7- or 8-oxo-cycloalkano[b]thien-4-ylureas and use thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH87775A CH619703A5 (en) | 1974-01-25 | 1975-01-24 | Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1016878A CH619705A5 (en) | 1974-01-25 | 1978-09-29 | Process for the preparation of N-formyl-7-oxocyclohexano- or -8-oxocycloheptano[b]thiophene-4-amines |
CH1016778A CH619949A5 (en) | 1974-01-25 | 1978-09-29 | Process for the preparation of novel 7- or 8-oxo-cycloalkano[b]thien-4-ylureas and use thereof |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS51125069A (en) |
AT (1) | AT353590B (en) |
CA (1) | CA1060899A (en) |
CH (4) | CH619703A5 (en) |
CS (1) | CS195276B2 (en) |
DD (4) | DD119790A5 (en) |
DE (1) | DE2501788C2 (en) |
DK (1) | DK22775A (en) |
ES (1) | ES434095A1 (en) |
FR (1) | FR2333801A1 (en) |
GB (1) | GB1499582A (en) |
IE (1) | IE42039B1 (en) |
IL (1) | IL46375A (en) |
IN (1) | IN141050B (en) |
IT (1) | IT1035548B (en) |
LU (1) | LU71711A1 (en) |
NL (1) | NL7500845A (en) |
PH (1) | PH14544A (en) |
SE (1) | SE421617B (en) |
TR (1) | TR18381A (en) |
YU (1) | YU36721B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994924A (en) * | 1975-11-04 | 1976-11-30 | American Cyanamid Company | 4,5,6,7-Tetra hydro-7-oxobenzo(B)thien-4-yl isocyanate and isothiocyanate |
FR2430231A1 (en) * | 1978-07-04 | 1980-02-01 | American Cyanamid Co | 4,5,6,7-Tetra:hydro-benzo(b)thienyl-4 urea and 7-oxo deriv. compsn. - used for increasing growth of wool and ratio of sec. to prim. follicles in sheep, goats, llamas, rabbits and chinchilla |
JPS6169772A (en) * | 1984-12-04 | 1986-04-10 | アメリカン サイアナミッド カンパニ− | Tetrahydrobenzo(b)thiophene derivative, manufacture and animal growth acceleration |
EP1801098A1 (en) * | 2005-12-16 | 2007-06-27 | Merck Sante | 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
-
1974
- 1974-12-31 CA CA217,189A patent/CA1060899A/en not_active Expired
-
1975
- 1975-01-01 IL IL46375A patent/IL46375A/en unknown
- 1975-01-02 IN IN20/CAL/75A patent/IN141050B/en unknown
- 1975-01-06 IE IE26/75A patent/IE42039B1/en unknown
- 1975-01-10 PH PH16699A patent/PH14544A/en unknown
- 1975-01-14 GB GB1592/75A patent/GB1499582A/en not_active Expired
- 1975-01-17 DE DE2501788A patent/DE2501788C2/en not_active Expired
- 1975-01-21 AT AT42675A patent/AT353590B/en not_active IP Right Cessation
- 1975-01-22 CS CS75448A patent/CS195276B2/en unknown
- 1975-01-23 LU LU71711A patent/LU71711A1/xx unknown
- 1975-01-23 FR FR7502174A patent/FR2333801A1/en active Granted
- 1975-01-24 NL NL7500845A patent/NL7500845A/en not_active Application Discontinuation
- 1975-01-24 DD DD183814A patent/DD119790A5/xx unknown
- 1975-01-24 DD DD192557A patent/DD125213A5/xx unknown
- 1975-01-24 DK DK22775*BA patent/DK22775A/da not_active Application Discontinuation
- 1975-01-24 DD DD192556A patent/DD125212A5/xx unknown
- 1975-01-24 ES ES434095A patent/ES434095A1/en not_active Expired
- 1975-01-24 CH CH87775A patent/CH619703A5/en not_active IP Right Cessation
- 1975-01-24 SE SE7500793A patent/SE421617B/en not_active IP Right Cessation
- 1975-01-24 YU YU0172/75A patent/YU36721B/en unknown
- 1975-01-24 DD DD192555A patent/DD125211A5/xx unknown
- 1975-01-24 IT IT47844/75A patent/IT1035548B/en active
- 1975-01-25 JP JP50010184A patent/JPS51125069A/en active Granted
- 1975-01-27 TR TR18381A patent/TR18381A/en unknown
-
1978
- 1978-09-29 CH CH1016678A patent/CH619704A5/en not_active IP Right Cessation
- 1978-09-29 CH CH1016878A patent/CH619705A5/en not_active IP Right Cessation
- 1978-09-29 CH CH1016778A patent/CH619949A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1035548B (en) | 1979-10-20 |
DE2501788A1 (en) | 1975-07-31 |
CH619705A5 (en) | 1980-10-15 |
IL46375A (en) | 1982-04-30 |
NL7500845A (en) | 1975-07-29 |
CS195276B2 (en) | 1980-01-31 |
IN141050B (en) | 1977-01-15 |
TR18381A (en) | 1977-05-01 |
DE2501788C2 (en) | 1984-11-08 |
GB1499582A (en) | 1978-02-01 |
JPS51125069A (en) | 1976-11-01 |
IL46375A0 (en) | 1975-04-25 |
IE42039B1 (en) | 1980-05-21 |
CH619703A5 (en) | 1980-10-15 |
AT353590B (en) | 1979-11-26 |
SE7500793L (en) | 1975-07-28 |
JPS6133830B2 (en) | 1986-08-04 |
SE421617B (en) | 1982-01-18 |
CH619949A5 (en) | 1980-10-31 |
DK22775A (en) | 1975-09-15 |
YU17275A (en) | 1982-06-18 |
DD119790A5 (en) | 1976-05-12 |
CA1060899A (en) | 1979-08-21 |
YU36721B (en) | 1984-08-31 |
DD125213A5 (en) | 1977-04-06 |
ES434095A1 (en) | 1977-05-16 |
IE42039L (en) | 1975-07-25 |
AU7691574A (en) | 1976-07-01 |
DD125211A5 (en) | 1977-04-06 |
PH14544A (en) | 1981-09-24 |
FR2333801B1 (en) | 1982-07-09 |
LU71711A1 (en) | 1975-06-24 |
FR2333801A1 (en) | 1977-07-01 |
ATA42675A (en) | 1979-04-15 |
DD125212A5 (en) | 1977-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0004334B1 (en) | Carbamates and their pesticidal compositions, preparations thereof and use thereof as pesticides | |
EP0202538B1 (en) | Growth promoting agents | |
DE1620114C3 (en) | Schiff bases of 2 formyl quinoxaline 1,4 dioxides | |
EP0223140A2 (en) | Thieno-oxazinones, process for their preparation and their use as development promoters | |
DE2505301A1 (en) | UREIDOTETRALINE AND METHOD OF MANUFACTURING IT | |
DD145997A5 (en) | MEDIUM FOR THE PROTECTION OF PLANT CULTURES | |
DE2648248A1 (en) | SUBSTITUTED TETRAHYDROBENZOTHIOPHENA, METHOD FOR THEIR PRODUCTION AND THEIR USE | |
CH635327A5 (en) | 2-formylchinoxalin-1,4-dioxide-cyanacetylhydrazone, method for the production and the same compositions. | |
CH619704A5 (en) | Process for the preparation of novel optionally ring-substituted cycloalkano[b]thiophene ureas or thioureas and use thereof | |
DE2130919A1 (en) | Substituted diphenyl ethers, process for their preparation and their use as herbicides | |
DE2731885A1 (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-4-IMINO-1-NAPHTHYL URUBE | |
DD233293A5 (en) | MEANS TO DELAY THE EFFECT OF HERBICIDAL PREPARATIONS | |
DE2815340C2 (en) | ||
EP0256420A2 (en) | Heteroarylethyl amines, process for their synthesis and their use in the promotion of animal performance | |
DD219102A5 (en) | COMPOSITION WITH INSECTICIDER AND ACARICIDAL EFFICACY | |
DE2940765A1 (en) | SUBSTITUTED ALKYLAMONIUM SALTS, THEIR PRODUCTION, THEIR USE FOR REGULATING THE PLANT GROWTH AND MEANS THEREFORE | |
DE3525336A1 (en) | ARYLETHANOLHYDROXYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR PROMOTING PERFORMANCE | |
US3944567A (en) | Benzothienylisocyanates and isothiocyanates and method of preparation thereof | |
US3993677A (en) | 1,2,3,4-Tetrahydro-4-oxo-1-naphthylisocyanate | |
US3972895A (en) | Benzothienylisothiocyanates | |
EP0093949B1 (en) | Sulfinyl and sulfonylazacycloheptan-2-ones, process for their preparation and their use as feed additives | |
DE69019536T2 (en) | OLIGOMER THIOKARBONATE. | |
DE3522938A1 (en) | PERFORMANCE MEANS | |
DD157072A5 (en) | METHOD FOR CONTROLLING MICRO-GROWING INSECTS | |
US4069231A (en) | Benzothienylisocyanates and isothiocyanates and method of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |